If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJDS.L Regulatory News (JDS)

  • There is currently no data for JDS

Directorate Change

5 Mar 2020 09:21

RNS Number : 1288F
Jardine Matheson Hldgs Ltd
05 March 2020
 

Jardine Matheson Holdings Limited

Directorate Change

 

Jardine Matheson Holdings Limited (the 'Company') announces that, with effect from 15th June 2020, the roles of Executive Chairman and Managing Director, which have been held on a combined basis by Ben Keswick since December 2018, will revert to being separate roles.

 

Ben Keswick will remain as Executive Chairman and John Witt, currently Group Finance Director, will take on the role of Managing Director.

 

John joined Jardines in 1993 and held a range of senior roles across the Group's core businesses and geographies, including as chief financial officer of Hongkong Land and Mandarin Oriental, before being appointed to the Jardine Matheson Board in 2016.

 

John will also be a director of Jardine Strategic Holdings Limited and the Group's listed subsidiaries, Hongkong Land Holdings Limited, Dairy Farm International Holdings Limited and Mandarin Oriental International Limited. He will also continue to be a commissioner of Astra and chairman of the Astra Excom.

 

Graham Baker will replace John as Group Finance Director and will join the Group on 1st June 2020 from Smith + Nephew in the United Kingdom, where he has been a board member and chief financial officer since March 2017. Graham will join the Board of the Company.

 

Prior to joining Smith + Nephew, Graham worked for 20 years for AstraZeneca PLC in a range of senior roles in the UK and internationally, including in Japan and Singapore, and then as chief financial officer of generic pharmaceuticals company Alvogen.

 

Commenting on the changes, Ben Keswick said:

"I am confident that these appointments will strengthen and enhance the effectiveness of the Group's leadership as we respond to the challenges and opportunities we face in positioning Jardines for continuing long term success."

 

- end -

 

For further information please contact

 

Investor enquries:

Jonathan Lloyd

Jardine Matheson Limited

 

(852) 2843 8223

 

Media enquiries:

Brunswick

Tom Burns

 

(44) 207 404 5959

David Ashton

(852) 3512 5063

 

This and other Group announcements can be accessed at www.jardines.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUPUBAWUPUURA
Date   Source Headline
27th Jul 201210:53 amRNSJC&C 2012 Half Year Financial Statements
27th Jul 201210:21 amRNSHalf Yearly Report
26th Jul 201211:20 amRNSAstra 2012 Half Year Financial Statements
28th Jun 201211:01 amRNSNotice of 2012 Half-Yearly Results
11th Jun 201210:15 amRNSDirector Declaration
31st May 201211:34 amRNSTotal Voting Rights
16th May 201210:24 amRNSDirector/PDMR Shareholding
11th May 201210:08 amRNSAdditional Listing
10th May 20123:39 pmRNSAGM Statement
10th May 20123:36 pmRNSResult of AGM
10th May 201212:34 pmRNSInterim Management Statement
3rd May 201211:15 amRNSAnnual Information Update
2nd May 201210:17 amRNSDividend
27th Apr 201210:12 amRNSDirector Declaration
25th Apr 201210:52 amRNSJC&C Q1 Results
25th Apr 201210:47 amRNSAstra First Quarter Results
23rd Apr 201210:41 amRNSDividend
11th Apr 201210:16 amRNSAnnual Financial Report
2nd Apr 201210:43 amRNSDirector Declaration
27th Mar 201210:12 amRNSCirc re. Scrip Dividend Scheme
2nd Mar 20129:06 amRNSFinal Results
29th Feb 20129:36 amRNSJC&C Full Year Financial Results 2011
27th Feb 201210:25 amRNSAstra 2011 Full Year Financial Statements
6th Feb 20129:32 amRNSNotice of 2011 Final Results
15th Dec 201110:36 amRNSShares Purchase
14th Dec 201111:04 amRNSShares Purchase
2nd Dec 201111:34 amRNSShares Purchase
9th Nov 20119:15 amRNSInterim Management Statement
1st Nov 20119:30 amRNSJC&C 3rd Quarter Financial Results
31st Oct 201110:30 amRNSTotal Voting Rights
31st Oct 201110:15 amRNSAstra 2011 3rd Quarter Financial Statements
12th Oct 201111:48 amRNSDirector/PDMR Shareholding
6th Oct 201110:28 amRNSAdditional Listing
3rd Oct 201110:21 amRNSDirector Declaration
29th Sep 201111:09 amRNSDirectorate Change
28th Sep 201110:24 amRNSDividend
26th Sep 201111:22 amRNSDividend
21st Sep 201112:00 pmRNSShares Purchase
20th Sep 201111:01 amRNSShares Purchase
31st Aug 201110:11 amRNSCirc re. Scrip Dividend Scheme
29th Jul 201110:14 amRNSJC&C 2011 Half Year Financial Statements
29th Jul 201110:13 amRNSHalf Yearly Report
28th Jul 201110:26 amRNSAstra 2011 Half Year Financial Results
30th Jun 201110:21 amRNSNotice of 2011 Half-Yearly Results
20th Jun 20117:00 amRNSShares Purchase
17th Jun 201111:55 amRNSHolding(s) in Company
8th Jun 201111:56 amRNSShares Purchase
3rd Jun 201111:18 amRNSShares Purchase
31st May 201110:33 amRNSTotal Voting Rights
31st May 20117:00 amRNSShares Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.